Patient attitudes to type specific serological tests in the diagnosis of genital herpes

被引:0
|
作者
Fairley, I
Monteiro, EF
机构
来源
GENITOURINARY MEDICINE | 1997年 / 73卷 / 04期
关键词
genital herpes; serology; patient attitudes;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To assess patient attitudes to HSV-2 serotesting and the effect of providing detailed information regarding genital herpes, the blood test, and its implications. Methods: Consecutive genitourinary medicine clinic attenders were asked to complete an anonymous self administered questionnaire. Half received minimal additional information while the other half received a detailed information sheet. Results: Overall, 200 clinic attenders with a median age of 27 years (range 15-57) completed the questionnaire, 92.4% wanted to know if they, and 90.8% if their partners, had been infected with genital herpes; 65% expected testing as part of screening without further discussion. Overall, on a scale of 1-10, 2% scored 1 (equivalent to definitely not wanting a test), while 45.5% scored 10 (equivalent to definitely wanting a test). The overall median score was 9 (95% confidence interval 8-10) suggesting a strong opinion in favour of testing. The desire to test in each of five described hypothetical situations increased significantly (p < 0.001) when compared with the general desire. Conclusions: Clinic attenders expressed a strong preference to be serotested for HSV-2 which was unaltered by the provision of information highlighting implications, although influenced significantly by the context in which they were asked. Should reliable tests become available the level of demand could have important implications on laboratory and counselling resources.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 50 条
  • [21] THE COMBINED USE OF TREPONEMIN SKIN TESTING AND SPECIFIC SEROLOGICAL TESTS IN THE DIAGNOSIS OF SYPHILIS
    PEARSON, RW
    PORTNOY, J
    MAGNUSON, HJ
    WHEELER, AH
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1958, 31 (01) : 75 - 81
  • [22] Tests of vaginal microbicides in the mouse genital herpes model
    Zeitlin, L
    Whaley, KJ
    Hegarty, TA
    Moench, TR
    Cone, RA
    CONTRACEPTION, 1997, 56 (05) : 329 - 335
  • [23] Genital herpes: Overcoming barriers to diagnosis and treatment
    Andrist, LC
    AMERICAN JOURNAL OF NURSING, 1997, 97 (10) : AAA16 - &
  • [24] NEW POTENTIALITIES IN THE LABORATORY DIAGNOSIS OF GENITAL HERPES
    EBRALIDZE, LK
    KHAMAGANOVA, IV
    MALTSEVA, NN
    VESTNIK DERMATOLOGII I VENEROLOGII, 1991, (06) : 23 - 26
  • [25] Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment
    Melville, J
    Sniffen, S
    Crosby, R
    Salazar, L
    Whittington, W
    Dithmer-Schreck, D
    DiClemente, R
    Wald, A
    SEXUALLY TRANSMITTED INFECTIONS, 2003, 79 (04) : 280 - 285
  • [26] Recurrent Vulvitis Patient with genital Herpes and Candidiasis
    Hoyme, Udo B.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2013, 73 (08) : 775 - 775
  • [27] Varicella vaccination in a patient with recurrent genital herpes
    Palmer, Bret
    SEXUALLY TRANSMITTED INFECTIONS, 2022, 98 (06) : 462 - 462
  • [28] Frequency of herpes simplex virus in Syria based on type-specific serological assay
    Ibrahim, AI
    Kouwatli, KM
    Obeid, MT
    SAUDI MEDICAL JOURNAL, 2000, 21 (04) : 355 - 360
  • [29] The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection
    Rosenthal, SL
    Zimet, GD
    Leichliter, JS
    Stanberry, LR
    Fife, KH
    Tu, W
    Bernstein, DI
    SEXUALLY TRANSMITTED INFECTIONS, 2006, 82 (02) : 154 - 157
  • [30] Patient and physician partnerships in managing genital herpes
    Alexander, L
    Naisbett, B
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 : S57 - S65